Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

NCT05166031 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor decided not to conduct it

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: bOPV and nOPV2

Sponsor

Fidec Corporation

Collaborators

[object Object]